SCHEMBL3344731

SCHEMBL3344731

NC(=O)c1ccc2[nH]c(=O)c3cccn3c2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 15/20 0.59
AURKB Q96GD4 1/20 0.52
TP53 P04637 1/20 0.51
CDC7 O00311 2/20 0.45
PLK4 O00444 2/20 0.45
MAPK13 O15264 2/20 0.45
PDPK1 O15530 2/20 0.45
DYRK3 O43781 2/20 0.45
ERBB2 P04626 2/20 0.45
PRKCG P05129 2/20 0.45
ROS1 P08922 2/20 0.45
KIT P10721 2/20 0.45
SRC P12931 2/20 0.45
PHKG2 P15735 2/20 0.45
AKT1 P31749 2/20 0.45
AKT2 P31751 2/20 0.45
MATK P42679 2/20 0.45
MAPKAPK2 P49137 2/20 0.45
BLK P51451 2/20 0.45
IRAK1 P51617 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13056839 0.88 PARP1 (0.68) PARP1AURKBTP53CDC7PLK4
SCHEMBL3335735 0.88 PARP1 (0.59) PARP1AURKBTP53CDC7PLK4
SCHEMBL3338380 0.83 PARP1 (0.54) PARP1AURKBTP53CDC7PLK4
SCHEMBL31500071 0.83 PARP1 (0.54) PARP1AURKBTP53CDC7PLK4
SCHEMBL3336562 0.78 PARP1 (0.69) PARP1TP53KDM4EALDH1A1BRPF1
SCHEMBL2429766 0.77 PARP1 (0.65) PARP1TP53CDC7PLK4MAPK13
SCHEMBL22046017 0.77 TP53 (0.77) PARP1AURKBTP53CDC7PLK4
SCHEMBL9415645 0.77 PARP1 (0.65) PARP1AURKBTP53CDC7PLK4
SCHEMBL29673202 0.77 PARP1 (0.65) PARP1AURKBTP53CDC7PLK4
SCHEMBL9415611 0.77 PARP1 (0.65) PARP1AURKBTP53CDC7PLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152180-A1 4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP) ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152180-A1 4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP) PARP1, PARP2, PARP4 PARP1 1/4885AURKB 1008/4885TP53 228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.